| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $46.8M | +30.8% |
| Cost of Revenue | $43.9M | +14.5% |
| R&D Expense | $35.6M | +0.9% |
| SG&A Expense | $87.9M | +33.9% |
| Operating Income | -$85.0M | -24.6% |
| Pre-tax Income | -$79.0M | -15.9% |
| Income Tax | -$33K | -123.9% |
| Net Income | -$78.9M | -15.6% |
| EPS (Basic) | -$0.46 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $265.2M | — |
| Accounts Receivable | $2.3M | -65.7% |
| Inventory | $29.2M | +73.9% |
| Current Assets | $301.9M | +909.2% |
| Total Assets | $351.8M | -12.4% |
| Current Liabilities | $34.4M | +22.9% |
| Total Liabilities | $45.0M | -17.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$89.7M | -20.3% |
| Capital Expenditures | $14.1M | +41.5% |
| Investing Cash Flow | -$14.1M | -41.5% |
| Financing Cash Flow | $366.3M | +332.2% |
| Free Cash Flow | -$103.8M | -22.8% |
| -9.5% |
| EPS (Diluted) | -$0.46 | -9.5% |
| Stockholders' Equity |
| $306.8M |
| +678.1% |